Facilitators of, and barriers to, prostate cancer screening uptake: A descriptive phenomenological study of adult men in Namibia
- PMID: 40389971
- PMCID: PMC12087039
- DOI: 10.1186/s12894-025-01721-x
Facilitators of, and barriers to, prostate cancer screening uptake: A descriptive phenomenological study of adult men in Namibia
Abstract
Background: Prostate cancer poses a significant health risk for aging men, with a higher prevalence observed in individuals aged 40 and above. The objectives of this study were to describe the facilitators of, and barriers to, prostate cancer screening among men between the ages of 50 and 70.
Methods: The study employed a qualitative descriptive phenomenological design. Data were collected at the oncology and urology departments of an intermediate hospital in Oshana region, Namibia using a semi-structured interview guide. Individual, face-to-face interviews were held between September and October 2022, after which the data gathered were analyzed thematically following Colaizzi's 7-step method.
Results: Fifteen (15) participants took part in this study. The two major themes that were generated were: (1) Value of early detection, which described the participants' perceptions regarding the facilitators of prostate cancer screening; and (2) Potential threats to PCa screening, which described the participants' perceptions regarding the barriers to taking up cancer screening.
Conclusions: The study revealed modifiable barriers to PCa screening, including fear of stigmatization, lack of knowledge, and insufficient screening access, as well as facilitators that can be strengthened for successful prostate cancer screening, such as advanced age, history of prostate cancer, and social support. These findings emphasize the need to implement gender-specific campaigns that address masculinity, lack of knowledge, and cultural stigmatization.
Keywords: Aged; Early detection; Policy; Prostate-specific antigen; Stereotyping.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was carried out with the approval of the Ethical Committee of the School of Nursing and Public Health at the University of Namibia (SoNEC 112/2022) and the Ministry of Health and Social Services (Ref: 22/3/1/2). All the participants provided written informed consent before joining the study. The participants were also notified that they had the option to withdraw from the study at any point. The study adhered to the principles of the revised Declaration of Helsinki guidelines for medical research that involves human subjects. Consent for publication: Written informed consent obtained from the study participants was limited to participation and publication of data only without any identifying images. Competing interests: The authors declare no competing interests.
Similar articles
-
Prostate Cancer Knowledge, Beliefs and Screening Uptake among Black Survivors: A Qualitative Exploration at a Tertiary Hospital, Limpopo Province, South Africa.Int J Environ Res Public Health. 2024 Sep 15;21(9):1212. doi: 10.3390/ijerph21091212. Int J Environ Res Public Health. 2024. PMID: 39338095 Free PMC article.
-
Facilitators and barriers to nurses' compliance with continuous professional development requirements at a referral hospital in Oshana Region, Namibia.Curationis. 2025 Feb 19;48(1):e1-e8. doi: 10.4102/curationis.v48i1.2637. Curationis. 2025. PMID: 40035107 Free PMC article.
-
Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening.Cancer Causes Control. 2021 Aug;32(8):895-901. doi: 10.1007/s10552-021-01444-y. Epub 2021 May 15. Cancer Causes Control. 2021. PMID: 33991283 Free PMC article.
-
Facilitators and Barriers to Cancer Screening Participation Across Southeastic Asia: A Scoping Review.Psychooncology. 2025 Apr;34(4):e70139. doi: 10.1002/pon.70139. Psychooncology. 2025. PMID: 40181418 Free PMC article.
-
Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.Public Health. 2021 Jan;190:67-74. doi: 10.1016/j.puhe.2020.10.025. Epub 2020 Dec 21. Public Health. 2021. PMID: 33360029
Cited by
-
Engaging for equity: Lessons from a cross-sector partnership addressing prostate cancer risk in the black community.Res Involv Engagem. 2025 Jun 10;11(1):60. doi: 10.1186/s40900-025-00743-x. Res Involv Engagem. 2025. PMID: 40495230 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424. 10.3322/caac.21492. - PubMed
-
- Nascimento-Gonçalves E, Faustino-Rocha AI, Seixas F, Ginja M, Colaço B, Ferreira R, Fardilha M, Oliveira PA. Modelling human prostate cancer: rat models. Life Sci. 2018;203:210–24. 10.1016/j.lfs.2018.04.014. - PubMed
-
- Dickey SL, Cormier E, Whyte IVJ, Ralston PA. Intrapersonal and community factors associated with prostate cancer screening among African-American males in the US. Nursing: Res Reviews. 2016;28:33–42. 10.2147/NRR.S96399.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical